Carisoprodol is prescribed as part of a comprehensive treatment plan that includes rest, physical therapy, and other measures to help relax muscles following strains, sprains, and muscle injuries. It is available in tablet form and is typically taken orally three times a day and before bedtime. It is classified as a Schedule IV controlled substance.
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search Results for " Carisoprodol "
Carisoprodol Related Products
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Carisoprodol, pharmacopeial and non-pharmacopeial Carisoprodol impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Carisoprodol impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Carisoprodol-related products are thoroughly characterized. Carisoprodol products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.